You are here:

Call for project grants from across the UK from Action Medical Research and DEBRA UK

Published on


Action and Debra logos

Action Medical Research and DEBRA UK, the national research charity and patient support organisation for people living with epidermolysis bullosa (EB), are teaming up to fund a project grant in 2024 for translational research into EB in children.

EB is a group of genetic skin blistering conditions that cause the skin to blister and tear at the slightest touch causing excruciating pain, unbearable itch, and raw open wounds.

With this new funding you could play your part and work on a research project that could be transformational for thousands of children in the UK suffering with the everyday pain of living with EB.

Applications will be judged in open competition on both potential clinical impact and scientific quality. Applications for jointly funded applications must meet the remit of both charities.

Applications may be made for project grants of up to £200,000 and up to three years duration. Up to £200,000 of joint funding is available to spend on co-funded projects as part of this call. Principal Investigators must be based at UK institutions and awards can only be made to UK institutions. Researchers outside the UK can collaborate on UK based projects if appropriate.

Action Medical Research will continue to consider applications across the breadth of its remit. Applications for project grants that are not eligible for co-funding but meet the remit of Action Medical Research alone will also be considered.

For more information on Action’s remit and the project grant call see how to Apply For A Research Grant.

For more information on DEBRA and its remit see the DEBRA Research page

Questions regarding the round should be directed to Action Medical Research by email:

Closing date for outline applications Tuesday 27 February 2024 5pm

Please read before applying

Project Grant Applications Guidelines and Outline Form

Applications should be of the highest quality as the scheme is very competitive